EP 3956472 A1 20220223 - GENETIC RISK ANALYSIS FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDERS AND BEHAVIORAL MANAGEMENT THEREOF
Title (en)
GENETIC RISK ANALYSIS FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDERS AND BEHAVIORAL MANAGEMENT THEREOF
Title (de)
GENETISCHE RISIKOANALYSE FÜR AUFMERKSAMKEITSDEFIZIT/HYPERAKTIVITÄTSSTÖRUNGEN UND DEREN VERHALTENSMANAGEMENT
Title (fr)
ANALYSE DE RISQUE GÉNÉTIQUE POUR DES TROUBLES DE DE DÉFICIT DE L'ATTENTION/HYPERACTIVITÉ
Publication
Application
Priority
- US 201962835193 P 20190417
- US 2020028870 W 20200417
Abstract (en)
[origin: WO2020215026A1] Methods and kits for assessing severity index for genetic risks of attention deficit/hyperactivity disorders. The present invention further relates to methods for behavioral management thereof. The methods and kits provide a risk analysis score (termed a "genetic risk attention deficit disorder score" (or "GRADDS"). The method for behavioral management of those depending upon his or her GRADDS is the precision behavioral management (or PBM") protocol. This can include precision addiction management and pro-dopamine lifestyle therapies and measures.
IPC 8 full level
C12Q 1/6883 (2018.01)
CPC (source: EP)
C12Q 1/6883 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020215026 A1 20201022; CA 3137128 A1 20201022; EP 3956472 A1 20220223; JP 2022529179 A 20220617
DOCDB simple family (application)
US 2020028870 W 20200417; CA 3137128 A 20200417; EP 20725287 A 20200417; JP 2021562019 A 20200417